Estimate Recalculated Apr 11, 2025 09:46PM EST
Amir Nashat does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Morphic Holding, Inc., BIND Therapeutics, Inc, Receptos, Inc., Scholar Rock Holding Corp, FATE THERAPEUTICS INC, SELECTA BIOSCIENCES INC, Metacrine, Inc., Syros Pharmaceuticals, Inc., and aTYR PHARMA INC.
Amir Nashat's CIK is 0001575843
2021 was Amir Nashat's most active year for acquiring shares with 7 total transactions. Amir Nashat's most active month to acquire stocks was the month of May. 2024 was Amir Nashat's most active year for disposing of shares, totalling 7 transactions. Amir Nashat's most active month to dispose stocks was the month of July. 2023 saw Amir Nashat paying a total of $0.00 for 88,078 shares, this is the most they've acquired in one year. In 2024 Amir Nashat cashed out on 99,308 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!